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    INTRODUCTION 
 
 “(He) that hath his privy member cut off shall not enter into the assembly of the lord” – 
(Deuteronomy 23:1) 130 
 
 The prospect of losing a part or the entire penis has been a cause of considerable distress in 
patients with carcinoma penis(132).  Hanash and colleagues (131) have reported on 3 patients who 
committed suicide after penile amputation. 
 
 The incidence of carcinoma penis is only 1% of malignancies in men in developed countries 
like United States. But the incidence is high in developing countries like India. The stage at 
presentation also differs in developing countries and most of them present in late stages due to 
multiple factors. Though newer approaches like topical agents, Mohs micrographic surgery, laser 
therapy and radiotherapy may be used in early stages, surgery has remained the gold standard in 
carcinoma penis for many years. 
 
 “But if a cancer should infect the penis, the morbid parts are, in that case, to be immediately 
divided from the rest, to prevent the disorder from spreading into the adjacent sound parts, to the 
destruction of the patient.” 
        -Heister’s surgery, 1739. 
 
 Carcinoma penis is one of the few diseases that, when metastatic to regional lymph nodes, can 
be cured by regional lymphadenectomy. Involvement of the inguinal lymph nodes is the single most 
important prognostic factor and ilio-inguinal block dissection offers high survival rates. 
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 The difficulty in the regional node management in carcinoma is that 50% of the clinically 
palpable nodes at presentation are due to infection and turn to be pathologically negative and 20% of 
clinically negative nodes at presentation harbor microscopic metastasis and prove positive 
pathologically. 
 
 However, ilioinguinal block dissection cannot be applied blindly to all patients of carcinoma 
penis as many of them may not warrant it and the procedure itself carries its own morbidity and 
complications. 
 
 Hence proper selection of patients is required to identify those who require regional 
lymphadenectomy in spite of clinically impalpable nodes and those who do not require regional 
lymphadenectomy in the node negative as well as the clinically node palpable group. 
 
 This study analyses the clinical and post surgical histopathological status of the nodes in both 
clinically positive and negative nodes at presentation. 
 
 This study also analyses the various epidemiological, etiological, pathological factors, clinical 
presentation and the management options for the primary lesion and the regional lymph nodes. 
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AIMS OF STUDY 
 
 
 
1. To study and analyze the incidence, etiological factors, stage of presentation, mode of 
presentation, treatment policy etc., in the carcinoma penis patients at Government Royapettah 
hospital, Kilpauk medical college, Chennai and compare them with studies available in the 
literature. 
 
 
2. To study the incidence of pathological involvement of inguinal nodes and compare it with 
clinical assessment. 
 
                                                                                                                                                                    
 4
 
REVIEW OF LITERATURE 
 
ANATOMY OF PENIS 
 
   The penis is composed of three tubular structures, each individually encased by the tunica 
albuginea, a thick fibro muscular sheath. Dorsally are paired corpora cavernosa (erectile bodies) that 
attach to the pubic arch by crural elongations. Fibro muscular trabeculae arising from the tunica 
albuginea penetrate the corporal bodies, dividing them into cavernous spaces. These become engorged 
with blood during sexual arousal producing penile erection. 
 
   Ventrally is the corpus spongiosum through which runs the urethra. The tunica albuginea of 
the corpus spongiosum is thinner and more elastic than that surrounding the corpora cavernosa. 
 
   Buck’s fascia, deep layer of superficial abdominal fascia, encloses the corpora cavernosa in 
one compartment and spongiosa in the other. This allows spongiosa to be readily dissected free of its 
attachments during urethrostomy. 
 
   The ischiocavernosus and bulbospongiosus muscles lie above Buck’s fascia but beneath the 
superficial penile and colles fascia. 
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BLOOD SUPPLY  
   The penis is supplied by two arterial systems: superficial from the external pudendal arteries 
and deep from the internal pudendal arteries. 
 
   The superficial blood supply lies above the Buck’s fascia and consists of paired superficial 
penile arteries that divide into dorsolateral and ventrolateral branches. Most of the blood to the penis, 
however, arises from the internal pudendal arteries (anterior branches of hypogastric) that bifurcate to 
form the perineal artery and the penile artery. 
 
   The penile artery pierces the urogenital diaphragm along the medial margin of the inferior 
ischial ramus and divides into three branches: the bulbourethral artery, the cavernous artery and the 
deep dorsal artery. The bulbourethral artery is usually short and of large caliber, pierces Buck’s fascia 
and enters bulbospongiosum. The dorsal artery runs along the dorsum of the penis and produces 3-10 
circumflex branches that course around the lateral surface of the corpora. Its terminal branch supplies 
the glans penis. The cavernosal artery enters the corpora cavernosa and runs the penile shaft, 
generating small vessels (helicine arteries) that constitute the erectile apparatus. 
 
   The penis is drained by three venous systems: superficial, intermediate and deep (5) (6) (7). The 
superficial veins located in the dartos fascia on the dorsal lateral aspects of the penis join at the penile 
base to form single superficial vein that, most frequently enters the left vein. 
   The intermediate system consists of the deep dorsal and circumflex veins, located below 
Buck’s fascia. They originate from small veins within the erectile spaces and those emerging from the 
glans penis. 
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   The deep drainage system consists of the crural and cavernosal veins, which empty into 
either the deep dorsal vein or the periprostatic plexus. The veins of these three systems have variable 
communication with each other. 
 
LYMPHATICS 
 
 The glans penis is drained by 3 lymphatic channels, through skin, through the mucosa and one 
beneath the mucosa. The trunks of all three drain to the frenum where they may communicate with the 
lymphatics from the urethra. 
 
 From the frenulum, the lymphatics ascend circumferentially around the coronal sulcus, 
forming one to major collecting trunks dorsally that run proximally beside the deep dorsal veins to the 
suspensory ligament of the penis. At the level of suspensory ligament, these lymphatics anastamose 
with each other and creates the presymphyseal plexus, which drains to the superficial inguinal nodes. 
 
 The lymphatics of the prepuce, both inner and outer surfaces and of the penile skin converge 
on the dorsum of the penis and form several trunks that run to the base of the penis, where they 
desiccate and drain into superficial inguinal nodes. These anastamosis place the patient at risk for 
bilateral nodal involvement. 
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INNERVATION 
 Penis is supplied with both somatic and autonomic nerves. Somatic nerves are from the spinal 
nerves s2-s4 through pudendal nerve. First branch of the pudendal nerve, the dorsal nerve of the penis, 
runs over the surface of the obturator internus muscle and under the levator ani on the medial side of 
the internal pudendal vessels and penetrates the urogenital diaphragm to reach the dorsum of the penis. 
Dorsal nerves continue along their respective dorsolateral penile surfaces, lateral to the dorsal artery. 
The main cutaneous nerve supply of the penis and scrotum originates from the branches of these 
dorsal nerves. 
 
 Autonomic innervations arise from the pelvic plexus, derived from fibers originating from the 
parasympathetic nerves S2,3,4 and sympathetic nerves T11-L2. Beyond the prostate, the 
parasympathetic nerves run adjacent to the membranous urethra, pierce the urogenital diaphragm and 
enter the corpora cavernosa. 
 
ANATOMY OF THE GROIN 
Since the treatment of carcinoma penis also involves the regional lymph node dissection, 
thorough anatomy of the groin is essential. 
 Inguinal lymph nodes are usually the first barriers against the lymphatic spread of the 
cancer metastasizing from the skin of the lower extremity and from the scrotum, labia, perineum, and 
perianal region, and umbilicus, infraumbilical part of the abdominal wall, clitoris, penis and glans. In 
addition inguinal nodes may receive metastases from prostate, urinary bladder, testis, epididymis, 
spermatic cord, ureter, kidney and urethra (9). Groin dissection has become the integral part of urologic 
surgical management of these malignant diseases. 
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 FEMORAL TRIANGLE   BASE OF FEMORAL TRIANGLE 
                      
 
 
WARTY GROWTH 
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FEMORAL TRIANGLE (SCARPA’S TRIANGLE) 
 Inguinal ligament forms the base of the triangle. Sartorius forms the lateral border and 
adductor longus forms the medial border, apex pointing downwards. Floor of the triangle is formed 
from lateral to medial by iliacus, psoas major and sometimes a small part of adductor brevis. Fascia 
lata covers the triangle leaving a small opening – fossa ovalis, through which the long saphenous vein 
enters the femoral vein. Femoral vessels pass from the middle of the base of the triangle to its apex. 
For the first 4 cm, these vessels are surrounded by the femoral sheath, formed by extensions of the 
abdominal fasciae that pass under the inguinal ligament. 
 The femoral sheath has two partitions dividing it into 3 compartments. The lateral most 
contains the femoral artery. Intermediate compartment contains the femoral vein. Smaller medial 
compartment is called the femoral canal and contains fatty areolar tissue in which lies the node of 
cloquet or node of Rosen Muller.  
 
 Femoral canal is reported to be present only in humans where it has a protective function. On 
standing upright, the femoral vein expands suddenly and the femoral canal protects the vein from the 
sharp edge of lacunar ligament. Femoral nerve lies outside the femoral sheath. Femoral artery is the 
continuation of external iliac artery and continues as popiliteal artery at the opening of adductor 
magnus at the junction of middle and lower thirds of the thigh. 
 
 Within the femoral triangle, femoral artery gives many branches. The most important of them 
are superficial epigastric, superficial circumflex iliac, superficial external pudendal and the deep 
femoral (profunda femoris) artery. Other branches supply the sartorius, vastus medialis and adductor 
muscles. 
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 The deep femoral artery arises from the lateral and posterior part of femoral artery 2.25 – 5 cm 
below the inguinal ligament. It can also originate from the external iliac artery or from medial or 
posterior part of femoral artery. 
 
INGUINAL LYMPH NODES 
 Inguinal lymph nodes are grouped in many ways. Some investigators separate the nodes by a 
horizontal line that crosses the thigh at sapheno femoral junction. Those nodes above the line are 
termed “superficial inguinal”. Those below are called “sub inguinal nodes”. The Sub inguinal nodes 
are further sub classified into superficial (those above the fascia lata) and deep nodes (those beneath 
fascia lata). This classification is cumbersome and the common classification is based on that 
suggested by Rouviere (12). Based on this, inguinal nodes are of two types: superficial and deep. 
 
SUPERFICIAL INGUINAL NODES 
 Inguinal region consists of 4-25 nodes. On an average, 8 nodes are present. In the absence of 
infection or malignancy, their size varies with the number. These group of nodes were originally 
thought to be bounded by the inguinal ligament above, the intersection of sartorius & adductor longus 
below, vertical line from anterior superior iliac spine laterally and another vertical line from pubic 
spine medially(13). 
 But after about 450 dissections by Daseler and associates, these boundaries were modified. The 
nodes were encased in a quadrilateral area bounded superiorly by a line 12 cm long and parallel to and 
1 cm above the inguinal ligament and beginning medially just above the pubic tubercle; medially by a 
line 15 cm dropped perpendicularly downward from pubic tubercle; laterally 20 cm long line dropped 
                                                                                                                                                                    
 11
from the lateral limit of superior boundary and inferiorly transverse line 11cm connecting the lower 
limits of medial and lateral borders. 
 Quenu divided the superficial inguinal nodes into 5 groups by horizontal and vertical lines 
through saphenofemoral junction dividing the superficial nodes into superomedial, superolateral, 
inferomedial and inferolateral and a fifth group in front of long saphenous vein. 
 
SUPEROLATERAL 
• Skin of upper gluteal region 
• Lateral posterior abdomen below the umbilicus 
• Occasionally penile skin or prepuce , clitoris 
 
SUPEROMEDIAL 
 * Umbilical and infra umbilical portion * penile skin 
 * Vulva and parts of external genitalia  * perineum 
 * Prepucium clitoritidis    * scrotum 
 * Cutaneous anal area 
Within this group lies the sentinel lymph node of Cabanas (14) (15). 
 
INFEROMEDIAL 
 (usually absent) 
 * Medial aspect of thigh, leg and foot  * skin of perineum 
 * Penile skin, prepuce    * scrotum, vulva 
 * Cutaneous anal area    * rarely glans penis 
                                                                                                                                                                    
 12
 
INFEROLATERAL 
• skin of anterior, lateral and posterior surfaces of thigh, leg and foot 
• skin of caudal portion of gluteal region occasionally skin of perineum 
 
CENTRAL GROUP 
• usually a single node 
• drain skin of scrotum, penis and vulva and from other zones 
An additional node, the prepubic node may rarely be present anterior to pubic symphysis and carry 
metastasis from penis or clitoris and drain into superficial inguinal nodes.  
From superficial nodes, lymphatics drain into deep nodes or directly into ext iliac nodes. 
 
DEEP INGUINAL NODES 
* Located under the fascia lata and medial to femoral vein. Usually 1-3 in number 
* Constant of them is node of Cloquet or Rosen Muller located in the femoral canal. 
* Lymphatic drainage almost always involves the superficial inguinal nodes and then drains into 
external iliac nodes. Direct drainage to pelvic nodes skipping the superficial nodes may also occur. 
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INCIDENCE AND EPIDEMIOLOGY 
Carcinoma penis constitutes <1% of all cancers in the males in developed countries like US 
and 2% of urogenital cancers are carcinoma penis. The incidence is high in uncircumcised 
populations, where the incidence is 10 – 12% (16). Penile cancer is the most common genitourinary 
cancer in Paraguay representing 45% - 76% of all genitourinary malignancies (17). In Uganda, where 
circumcision is not practiced, penile cancer is the most commonly diagnosed cancer in males (18). The 
incidence rate of ca. penis in US is 1 case per 100000 men (19) (20). The incidence of penile cancer in a 
particular area or population is clearly influenced by cultural or religious practices and hygienic 
standards (21). In under developed countries, the incidence is 15%-20% (1). 
 
AGE: 
* The incidence of penile cancer increases with advancing age in all populations 
* But in areas of high incidence, earlier age of onset has been reported 
* Patients tend to be 50 – 70 years of age in developed countries. 
 
ETIOLOGY 
 
1. PHIMOSIS AND CIRCUMCISION 
 
       Retention of prepuce after new born period is an important factor in etiology (22). The incidence of 
penile cancer among uncircumcised population is thousand times higher than where newborn 
circumcision is the rule. However, circumcision after newborn period is less protective. 
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 Wolharst in 1932 was the first to indicate that neonatal circumcision has a protective effect. 
Other benefits of circumcision are prevention of urinary tract infection in infant boys and of sexually 
transmitted diseases in young men. Uncircumcised men appear to be more susceptible to sexually 
transmitted diseases that disrupt epithelial surfaces such as genital herpes, syphilis, condyloma 
acuminata and chancroid (23)(24)(25). 
 Maden and associates showed the risk of penile cancer as 3.2 times greater among men who 
had never been circumcised relative to men circumcised at birth and 3 times greater among men who 
had been circumcised after the neonatal period. 
 
2. SMEGMA 
 
Smegma, a product of bacterial action on desquamated epithelial cells is carcinogenic in animal 
systems, although the specific component responsible for malignant degeneration in human males 
has not yet been identified. Among men not circumcised at birth, the relative risk associated with 
the presence of smegma was 2.1 times higher in Maden et al study.  
 
3. HPV 
 
Human papilloma virus is a double stranded DNA icosahedron containing approximately 8000 
base pairs. (26) The use of polymerase chain reaction (PCR) and in situ hybridization (ISH) has 
helped to define the association of HPV with subsequent development of premalignant and 
malignant lesions of the penis. More than 65 types of HPV have been identified (27). The HPV that 
                                                                                                                                                                    
 15
infect the anogenital area can be separated into two different groups on the basis of their 
association with recognized clinical entities (28) 
 
The first group including HPV 6&11 is generally associated with benign condylomata, which 
are not associated with the subsequent development of penile cancer and are referred to as “low 
risk “ viruses (28)(29). The “high risk “group including HPV 16 &18 is associated with premalignant 
and malignant lesions of the cervix (28), (29), (30). Cloned viral genomes from high risk HPV s have 
been showed to transform cells in culture, a finding suggesting that those papilloma virus types 
may play an etiologic role in the development of these tumours (29). In an examination of 30 
specimens of penile cancer from 23 patients by PCR analysis, HPV 16 genome was found in15 
patients (65%), HPV 30 was found in 3 (13%) and HPV 6 or HPV 11 in 2 (9%). Similar study was 
also reported from Japan.  
 
These investigators demonstrated HPV 16 in a lymph node metastasis of penile cancer, the 
same HPV type as found in the primary tumour.  A study by Sarkar and his associates confirms a 
strong association of presence of HPV 16 DNA and the bowenoid forms of intraepithelial 
neoplasia characteristic of carcinoma in situ of both cervix and the penis as well as invasive 
carcinoma of these organs.  
 
 In summary, advances and techniques in molecular biology have shown an ever 
increasing association between infection with certain HPV sub types and the development of both 
penile and cervical cancer. This finding may explain the strong association of premalignant and 
malignant changes of the penis in men with large number of sexual partners. Common 
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epidemiological factors in men that are associated with increased incidence of penile cancer, such 
as phimosis or chronic inflammation of penis, may actually indicate a higher risk of HPV infection 
and subsequent malignant cellular transformation. 
 
4. OTHER FACTORS 
 
• Smokers had a 2.8 times increased risk when compared to non smokers in Maden & 
associates study. 
• Condyloma acuminata or penile warts showed 5.9 times increased risk. 
• Leucoplakia of glans penis. 
• Multiple sexual factors. 
• History of penile tear or rash. 
• Syphilis and gonorrhea have been implicated, but persistent etiologic relationship is yet 
unproven. 
 
     PATHOLOGY 
 
Penile carcinoma is most often squamous cell in origin, although malignant melanoma, 
basal cell carcinoma, Bowen’s disease (carcinoma in situ), mesenchymal tumors (including 
Kaposi sarcoma), adenocarcinoma (from Tyson’s glands), metastatic lesions and leukemia or 
lymphomatous infiltrates may involve the penis. Several premalignant lesions have been 
identified and are shown below. 
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  ERYTHROPLASIA OF QUEYRAT 
 
 
 
   LEUKOPLAKIA 
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 lesion            characteristics           treatment 
Leukoplakia White plaque Local excision 
Erythroplasia of Queyrat Raised, red velvety lesion 
cellular disorientation with 
multiple mitosis identical to 
ca. in situ of skin 
Local excision 
Topical 5 FU 
Radiotherapy  
Bowen’s disease Red plaque Local excision 
Balanitis xerotica obliterans Scaly atrophic with ulceration 
meatus often involved 
Local excision 
Topical steroids 
 
 CLASSIFICATION OF PENILE MALIGNANCIES 
 
1. PRIMARY 
 
EPITHELIAL: 
1. Squamous cell carcinoma and its variants  4. Adenosquamous  
2. Carcinoma in situ     5. Merkel cell carcinoma 
3. Basal cell carcinoma    6. Adenocarcinoma 
NON EPITHELIAL: 
1. Melanoma 
2. Sarcoma  
 
2. METASTATIC 
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 1. SQUAMOUS CELL CARCINOMA 
 (More than 95% of all penile malignancies) 
 Grossly, the tumors appear as moderately well demarcated firm, centrally ulcerated 
masses. Histologically, approximately 50% of lesions are of low grade and infiltrate the 
underlying tissues in finger like projections often appearing as nests and cords in tissue 
sections (39).  Keratin pearls are identified in infiltrative areas. Depending on the degree of 
differentiation, the individual tumor cells may be delineated by intercellular bridges. The 
nuclei are pleomorphic with coarsely granular, irregularly distributed chromatin. Many nuclei 
have one or more prominent nucleoli. Mitoses are easily identified. Advancing tumor margins 
are surrounded by a dense, predominantly lymphocytic infiltrate. 
2. VARIANTS OF SQUAMOUS CELL CARCINOMA 
A) VERRUCOUS CARCINOMA (40) (Giant condyloma of Buschke-Lowenstein) 
This variant differs in following aspects. 
• predominantly papillary configuration 
• superficial “broad-front” invasive pattern 
• minimal cytologic atypia 
• metastasis uncommon 
Verrucous carcinoma accounts for 5-16% of all penile malignancies (41). They are 
distinguished from genital warts by their ability to invade and destroy adjacent tissue rather 
than their cytology (42). Pseudoepitheliomatosis, micaceous and keratotic balanitis, originally 
considered as benign condition (43) is currently classified as variant of verrucous carcinomas 
(44). This lesion lacks papillomatosis but has acanthosis, hyperkeratosis, increased mitosis, 
nuclear atypia, and a tendency towards recurrence and sarcomatous differentiation (45). 
                                                                                                                                                                    
 20
   
PEARLY PENILE PAPULES   
 
 
   CARCINOMA PENIS 
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B) SPINDLE CELL CARCINOMA (SARCOMATOID CARCINOMA)  
This is a rare variant of squamous cell carcinoma in which lesions appear as polypoidal 
masses on glans penis (46). Although thorough sampling has revealed areas of squamous 
differentiation, they are predominantly composed of spindle shaped cells embedded in a 
loose myxomatous stroma. These lesions tend to grow locally and appear to have a 
relatively favorable prognosis. 
B) BASALOID CARCINOMA 
This lesion resembles that of similar lesions of vulva and identifies a penile cancer with 
aggressive behavior. 
3. CARCINOMA IN SITU: 
This describes an intraepithelial neoplasm that may occur at various sites on the penis. 
When the lesion occurs on the glans, it is called Erythroplasia of Queyrat (18). Lesions 
appearing on skin of prepuce or penile shaft are called Bowen’s disease while those appearing 
as multiple nodules on the penile shaft are designated Bowenoid Papulosis (48) (49). 
Erythroplasia and Bowen’s are considered part of spectrum of squamous cell carcinoma. HPV 
DNA, type 16 has been documented in nearly every lesion (50) (51).  
Cytologically these lesions have acanthosis with widespread replacement of normal 
epithelium by anaplastic cells that have large nuclei surrounded by scanty cytoplasm. Cells 
with multiple nuclear lobes or nuclei with folded and flat surfaces are frequently encountered 
and occasional cells have perinuclear halos. Isolated cases of Paget’s disease and malignant 
penile horn the penis have been reported (52). Paget’s disease may also spread widely to involve 
skin of perineum, scrotum, groin and adjacent areas. Paget’s may also be associated with 
previous transitional cell carcinoma of urinary bladder (53). 
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4. OTHER RARE CARCINOMAS 
      These include basal cell, inflammatory, adenosquamous, Merkel cell and 
adenocarcinoma (54). Basal cell carcinomas can arise from penile shaft. The inflammatory 
and merkel cell cancers are aggressive. Isolated cases of skin appendage carcinomas have 
been reported (55). 
5. MELANOMA 
Melanomas are one of the more frequently occurring non-squamous cell malignancies of 
the penis (56). Most are deeply invasive at diagnosis and the prognosis is poor. Melanomas 
occur in the same distribution as carcinomas (glans> prepuce> coronal sulcus) 
6. NON EPITHELIAL NEOPLASMS 
Cases of osteosarcoma, chondrosarcoma, endodermal sinus tumor and leukemic and 
lymphomatous involvement of the penis have been reported (57). 
7. METASTATIC TUMOURS: 
Metastatic cancer involving the penis is a rare phenomenon despite the fact that the 
organ has a rich blood and lymphatic supply and is in close proximity to the bladder, prostate 
and rectum. Metastatic lesions usually fill the corpora cavernosa; small solitary metastases are 
less common. The most frequent primary sites are bladder, prostate, rectum, kidney, colon, 
urethra, testis, lung, pancreas, ureter, bone and upper respiratory tract. Five modes of 
metastasis to the penis have been described: 
1. Retrograde venous dissemination (most common) 
2. Retrograde lymphatic dissemination  4. Direct extension 
3. Arterial dissemination    5. Perineural tumor infiltration 
 These patients present with pain, swelling, priapism or alterations in voiding. 
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 GRADING: 
Most authorities agree that grading has practical value. The most popular scheme 
employs  three grades, the lowest grade being the best differentiated (83). Exact 
histological criteria that will allow most pathologists to reliably separate various grades of 
squamous cell carcinoma have not been adequately defined and disseminated. Grading has 
been justified because of its predictive value for regional lymph node metastases. Invasive 
penile carcinomas with grades other than 1 (well differentiated) have concomitant regional 
metastases in 80 – 100% of cases. Even so, approximately 50% of grade 1 tumors have 
concomitant nodal metastasis.    
 
 BRODER’S GRADING OF SQUAMOUS CELL CARCINOMA:  
   
GRADE   DIFFERENTIATION HISTOLOGICAL FEATURES 
       
Grade I 
 
Well differentiated 
*prominent intercellular bridges 
* prominent keratin pearls    * minimal atypia 
* rare mitotic figures 
 
Grade II 
/ III 
 
Moderately  
differentiated 
* occasional intercellular bridges 
* few keratin pearls              * greater nuclear atypia
* increased mitotic figures 
Grade 
IV 
Poorly differentiated * marked nuclear pleomorphism 
* numerous mitotic figures   * lymphatic invasion 
* necrosis, no keratin pearls  * vascular invasion 
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 CLINICAL FEATURES  
 Symptoms and signs associated with carcinoma penis are 
1. ULCER   
Patients usually present with an ulcer with indurated base most commonly over the glans 
prepuce or coronal sulcus in that order. This ulcer is usually painless. The lesion may be super 
infected 
2. SWELLING 
Patients may present with a proliferative mass. There may be ulceration and bleeding over the 
swelling. The swelling may be a small nodule or a papillary growth. The site of the lesion, 
either an ulcer or a swelling is usually the glans. In a review of larger series of penile cancer (62) 
the site distribution was found to be as below 
Glans 48% 
Prepuce 21% 
Both glans and prepuce 9% 
Coronal sulcus 6% 
Shaft 2% 
Invasion of shaft from more distal sites  14% 
 
As the lesion grows, it develops one of two typical growth patterns: exophytic or ulcerative. 
Exophytic or papillary tumors generally have a better prognosis than flat or ulcerative lesions 
because the latter tend to infiltrate more deeply and are less differentiated than exophytic 
tumors (64, 65). Characteristics of penile cancer that should be observed are the tumor 
configuration, size, location and fixation to the underlying Buck’s fascia, induration in shaft. 
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3. INGUINAL LYMPH NODES 
Patients may present with coexisting nodal mass in the groin or sometimes with nodes alone 
drawing the attention of the patient and the primary being hidden under phimosed foreskin. 
The inguinal areas in all cases of ca. penis should be palpated bilaterally to assess the nodal 
status and they should be mapped on the patients’ records for comparison with subsequent 
examinations. A ‘50% rule’ is applied here. 50% of cases of ca. penis have palpable nodes and 
among them 50% turn out to be malignant proved pathologically and the remaining 50% 
inflammatory.  
In contrast 20 – 30 % of patients without palpable inguinal nodes may harbor occult 
metastases. This percentage varies significantly with the severity of the primary tumor.  
The skin of the penis and lymphatics from the prepuce drain into superficial inguinal lymph 
nodes. Bilateral drainage occurs as a result of freely anastamosing system and cross over at the 
base of the penis. The glans is drained by the superficial inguinal lymph nodes but along with 
those of the corpora, the lymphatics of glans empty into deep inguinal and iliac nodes. The 
superficial lymphatics drain into the deep lymphatics and then to the external iliac, common 
iliac and para aortic nodes. Tumor invasion of the posterior may lead to deep pelvic nodes and 
internal iliac and obturator nodes. 
 
4. PAIN 
5. URINARY RETENTION / URINARY FISTULA – Rare 
6. BLEEDING 
7. SYSTEMIC SYMPTOMS :  
Weight loss, weakness, fatigue, malaise can occur 
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8. DISTANT METASTASIS 
Despite the rich vascularity of the corpora cavernosa, hematogenous spread is rare. Most 
tumors are disseminated through the inguinal and iliac nodes. Complications of treatment 
are more related to local recurrence and presence of bulky regional lymph node metastases 
than to wide spread dissemination of the disease. Distant metastases may occur in the lungs 
and bones. Only about 5% of penile cancer patients have distant metastasis at the time of 
diagnosis (80, 81, 82). 
9. NON SPECIFIC PRESENTATIONS 
Anemia  
Hypercalcemia - More frequently associated with advanced stages. 
 
 INVESTIGATIONS 
1. GENERAL INVESTIGATIONS:  
* Renal function tests, blood sugar, complete hemogram 
* Urine routine 
* ECG, CXR 
  2. SPECIFIC INVESTIGATIONS: 
   * To confirm diagnosis 
   * To stage the disease 
  3. OTHER NON SPECIFIC INVESTIGATIONS: 
   * Serum calcium  
* Serum proteins 
* Serum alkaline phosphate 
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 1. WEDGE BIOPSY 
In case of primary presenting as an ulcer, a wedge biopsy is taken from the edge of the 
ulcer as distally as possible and sent for histological examination. The pathological features 
that are expected in carcinoma penis are already discussed under the section “Pathology”. The 
wedge should include a portion of normal tissue because the malignant potential of a lesion can 
be observed by assessing the cellular interaction of the tumor with normal adjacent tissue and 
the nature and extent of invasion. Similarly, a biopsy should be deep enough to determine the 
lesions depth of penetration of underlying tissue.  
  
2. ULTRASONOGRAPHY 
Helps to assess the corporal involvement in penile cancer(90). Although this technique has had 
limited use in this manner, its ease of application, non invasiveness and low cost may make 
ultrasonography a useful diagnostic modality in staging penile cancer. 
  
3. COMPUTED TOMOGRAPHY 
 Computed tomography has not been shown to have any practical use in assessing the 
primary lesion in penile cancer because it does not enable the clinician to distinguish tumor 
from adjacent corporal tissue (92). However, CT is the most popular imaging technique for the 
detections of lymphadenopathy (92, 93, 94, 95). Identification and evaluation of the pelvic nodes 
may be more difficult than assessing para aortic nodes, because of the relative scarcity of fat 
enveloping the pelvic nodes and their oblique orientation. Further more, CT can only detect 
non specific lymph node enlargement. Nonetheless, this study is done routinely to determine 
the status of the pelvic nodes even in the absence of inguinal adenopathy. 
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4. MRI 
Magnetic resonance imaging is very useful in determining the extent and stage of the primary 
lesion (93, 94). Advantages include superior contrast and imaging in multiple planes. Studies of 
the normal penis have shown that the tunica albuginea enveloping the corpora has low signal 
intensity and the contrast between the tunica and the corpora is increased on T2 (transverse) 
weighted images (94, 95). Buck’s fascia is indistinguishable from the tunica on T2 weighted 
images but the two may appear as separate structures on T1 (longitudinal) weighted images (95).  
 MRI may also be used to assess the status of both inguinal and pelvic nodes in patients 
with penile cancer, although experience with this modality is limited (92-95). Although it has 
advantages of scanning in multiple planes, MRI also depends on enlargement of the lymph 
nodes in defining abnormality, and does not enable one to disseminate tumor from other cases 
of nodal enlargement (95). For these reasons, MRI imaging does not offer any clear advantage 
over CT in the evaluation of patients with nodal involvement in penile cancer. 
5. FNAC 
This is an ideal investigation in the staging of penile cancer because the lymph nodes 
are readily accessible and aspiration of the lymph nodes can be done under direct vision. An 
ideal use of FNAC would be in the patient who has negative or equivocal nodes at diagnosis 
and who has significant contraindication to inguinal node dissections, such as obesity, previous 
pelvic surgery or a history of cardiac or thrombo embolic disease. Negative results of fine 
needle aspiration of the inguinal lymph nodes would be reassuring when observation of the 
inguinal area is contemplated. FNAC when combined with imaging techniques enhances the 
diagnostic accuracy of those tests. With further advances in imaging techniques, fine needle 
aspiration may play more roles in patients with penile cancer in the future. 
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6. SENTINEL NODE BIOPSY 
Ramon Cabanas in 1968, introduced the concept of sentinel node during his work on 
Carcinoma of penis. Later on, this concept was extended to breast, melanoma, rectum etc (97).  
Based on previous lymphangiographic studies, cabanas defined the sentinel node as the 
primary site of metastasis for penile cancer, and this node is located on the anteromedial aspect 
of the superficial epigastric vein medial to and above the epigastric-saphenous junction. In his 
original series, cabanas reported that inguinal lymph node metastasis were absent in patients 
with negative sentinel lymph node biopsy and 80% of patients with a positive sentinel lymph 
node had no other nodal involvement, whereas regional spread was documented in the 
remaining 20%. However, Perinetti and colleagues (98) have reported patients with negative 
sentinel node biopsies who later developed unresectable bilateral groin disease. 
 
   STAGING OF CARCINOMA PENIS 
I. JACKSON’S STAGING SYSTEM (1966): 
 Stage I  Tumors confined to glans, prepuce or both 
 Stage II Tumors extending into the shaft of penis 
 Stage III Tumors with operable inguinal metastasis  
Stage IV Tumors associated with inoperable inguinal or distant metastasis 
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II. AJCC STAGING SYSTEM 
 From American joint committee on cancer (100), 1989. 
                                    T                                      N 
Tx – primary tumor cannot be assessed Nx – regional lymph nodes can’t be assessed 
To- no evidence of primary tumor No – no regional lymph node metastasis 
Tis- carcinoma in situ N1- metastasis in a single superficial lymph node
T1-tumor invades subepithelial 
connective tissue 
N2 -metastasis in multiple or bilateral superficial 
inguinal lymph nodes  
T2- involves corpus spongiosum or 
cavernosum 
N3- metastasis in deep inguinal or pelvic nodes. 
Unilateral or bilateral 
T3 -tumor involves urethra / prostate  
T4- tumor involves adjacent organs  
 
 
Mx – Presence of metastasis cannot be assessed. 
 
Mo -- No distant metastasis 
 
M1 – Distant metastasis 
 
 
III. UICC STAGING SYSTEM (UNION INTERNATIONALE CENTRE LE  
CANCER) 
 
T (Tumor) 
   
T o - None 
 
Tis - Carcinoma in situ 
 
T1 - Superficial, exophytic ≤2 cm 
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T2 - Minimal infiltration 2-5 cm 
 
T3 - > 5 cm, deep invasion, including urethra 
 
T4 - Invasion of adjacent structures 
 
 
 N (Nodes) 
 
  No - None palpable 
 
  N1 - Unilateral mobile 
 
  N2 - Bilateral mobile 
 
  N3 - Fixed 
 
 M (Metastasis) 
 
  M0 - None 
 
  M1 - Metastasis present, any site 
  
     MANAGEMENT 
Treatment depends on the local extent of the primary lesion and the status of the 
regional lymph nodes. Treatment comprises of  
1. Treatment of primary lesion 
2. Management of regional lymph nodes 
The options for primary are 
1. Surgery 
2. Radiotherapy 
3. Chemotherapy 
4. Combined 
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TREATMENT OF PRIMARY LESION 
      SURGERY 
Management of primary lesion involves total removal of the lesion with adequate tumor 
free margin, with the least possible cosmetic and functional loss. Therefore, surgery remains an 
important element in the management of penile cancer. Partial or total penectomy remains 
procedure of choice in bulky, exophytic penile cancer, which continues to be evident at 
diagnosis in many cases.  
     
 CIRCUMCISION: 
Circumcisions appear to have a fairly limited role as the sole treatment of penile cancer, 
because recurrence rates of 32 to 50% have been reported (109) (110) (111). For superficial lesions 
limited to the foreskin, however circumcision would appears to be an ideal form of 
management. Careful attention to the margins is necessary when circumcision is performed 
and it is helpful to mark the specimen clearly to assist the pathologist in examining the most 
critical margins 
 
 PARTIAL PENECTOMY: 
Partial penectomy is indicated for lesions that because of their size, invasiveness or 
location on the shaft are not amenable to more conservative treatment. 
Partial penectomy must ensure adequate penile length for voiding in upright position. If 
the stump is too short it may be engulfed by the groin pad of fat and the patient ends dribbling 
urine down both legs. Partial penectomy includes a 2 cm margin of normal shaft proximal to 
primary tumor and a stump of at least 3 cm should be present. 
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 TOTAL PENECTOMY: 
Where partial penectomy is not possible, total penectomy is accomplished with 
excision of both corpora and creation of a perineal urethrostomy. 
 
 PENILE RECONSRUCTION AFTER TOTAL PENECTOMY: 
Borgoras was the first to report penile reconstruction in 1936. He used tubed abdominal 
flaps with ribbed cartilage for rigidity. Other techniques that have been used are local tubed 
pedicle flaps and skin flaps, muscle and myocutaneous flaps, local fasciocutaneous flaps, and 
more recently sensate, fasciocutaneous microvascular free flaps (112). 
A fasciocutaneous forearm free flap is the usual tissue donor site, elevated on either the 
radial or ulnar artery and is transferred to the recipient site by microsurgical anastamosis to 
either the inferior epigastric vessels or through a vein interposition graft to the superficial 
femoral artery. The medial or lateral antebrachial nerves are included in the flap for cooptation 
to the dorsal nerves of the penis. 
 
 REGIONAL THERAPY AND LYMPHADENECTOMY: 
  Factors considered while planning the management of regional lymph nodes: 
• Firstly, involvement of lymph nodes is the single most important prognostic factor in 
cancer penis  
• Lymph nodes dissection can be curative for the majority of patients with isolated tumor 
bearing inguinal nodes 
These facts indicate that the management of the regional lymph nodes forms an integral 
part in management of cancer penis. However, only 50% of cancer penis patients have palpable 
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inguinal nodes at diagnosis, of which, 50% represent benign inflammatory changes associated 
with ulcerated or infected penile lesions. 
Hence, lymphadenectomy is not necessary in all cases of carcinoma penis with 
enlarged nodes. This problem is overcome by assessing the nodes after 4 to 6 weeks course of 
antibiotic therapy. Persistent adenopathy after 6 weeks warrants biopsy and therapy. 
But the primary controversy in the management of penile cancer concerns the role of 
lymph node dissection if there is no clinically identifiable inguinal disease. 
• 20% of clinically non palpable nodes harbor occult metastasis 
The management options available for such a group of patients are 
1. Prophylactic lymphadenectomy in non palpable groups also, or, 
2. Delay lymphadenectomy until clinically evident node involvement exists (therapeutic 
lymphadenectomy) 
 
ADVANTAGES OF PROPHYLACTIC LYMPHADENECTOMY: 
• If a prophylactic lymphadenectomy is done and microscopic metastasis are found 
pathologically, 84% survive 5 years where as in those patients in whom delayed 
lymphadenectomy is done, 8 – 42% survive 5 years. The cure rate therefore is much 
better if regional disease is removed when microscopic than palpable (5). 
• Complications of groin dissection are much less in those receiving a groin dissection 
for microscopic disease compared with delayed dissection of nodes that are palpably 
positive at a later date (113). 
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In a report by Uehling, when delayed lymphadenectomy is opted, the most common cause of 
treatment failure was progression to inoperable nodes in 22% of patients monitored (114). 
Studies have reported a significant decrease in 5 years survival rates in patients with 
therapeutic rather than prophylactic groin dissection and have suggested that delayed surgery is 
inappropriate (115).  
 Though these points favor a prophylactic lymphadenectomy for nodes not involved 
pathologically, this would lead to performance of such a dissection with survival benefit at a 
cost of increased morbidity. 
 If those patients without palpable lymph nodes who have microscopic nodal metastasis 
could be identified, they would certainly benefit from a lymphadenectomy. Methods to detect 
micro metastasis have not yet yielded consistent results. Some have suggested that a biopsy 
could provide information for making this decision. However, the experience of many is that 
lymph node biopsy carries a false negative rate if at least 50% (117) 
 Cabanas proposed that sentinel node biopsy would be helpful, but the lack of full 
follow up on some of the patients in that study (120) and the experience of many others suggest 
that this type of biopsy has a high rate of false negative results as well (121), therefore the use of 
regional biopsy to predict the presence of regional nodal disease does not appear appropriate. 
 Thus when it is not possible to detect microscopic disease in clinically non palpable 
nodes, another method to detect those patients who are likely to have microscopic disease 
should be adopted and selected for prophylactic nodal dissection, such as 
1. Grade of the lesion (differentiation) & 
2. Depth of invasion (T stage) 
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GRADE OF THE PRIMARY RATE OF REGIONAL NODAL INVOLVEMENT 
Poorly differentiated 82% 
Moderately differentiated 46% 
Well differentiated 24% 
 
In one series, all patients who had poorly differentiated tumors developed regional metastasis 
(113). The depth of invasion is also important in determining the likelihood of regional and 
distant metastasis. Lesions that do not involve the substance of corpus spongiosum or 
cavernosum have 5% - 11% rate of progression to regional disease (123,124). These superficial 
penile lesions have a 92% survival rate at 3 years (123). Since the differentiation of the primary 
lesion and the depth of invasion are important in predicting regional lymph node metastasis, a 
modification of Jackson system has been made to reflect current therapy. With this 
modification, appropriate determination of stage allows a reasonably certain prediction of the 
likelihood of positive regional lymph node involvement. 
 
   MODIFIED STAGING SYSTEM 
STAGE I : superficial, does not extend to subcutaneous tissue: well differentiated 
STAGE II A : locally invasive, without involvement of corpora: well or moderately 
differentiated 
STAGE II B : Invasion to corpora: poorly differentiated 
STAGE III : Palpable inguinal nodes that persist after 6 weeks of antibiotic therapy 
STAGE IV : Inoperable groin nodes, iliac nodal involvement, and distant metastasis 
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SURVIVAL ACCORDING TO MODIFIED STAGING SYSTEM 
  
STAGE DISEASE FREE 5 YEAR SURVIVAL 
I 100 % 
II A 100% 
II B 90% 
III 70% 
 
 (All patients had a regional lymphadenectomy shortly after treatment of primary) 
 Thus the T stage of the primary and the grading play a crucial role in planning the 
management of the regional lymph nodes. 
 
 COMPLICATIONS OF REGIONAL LYMPHADENECTOMY 
 
FLAP NECROSIS    5% 
WOUND INFECTION   15% 
LYMPHEDEMA LEGS/ SCROTUM  16% 
LYMPHOCELE    9% 
LOSS OF SKIN EDGES   30% 
WOUND SEROMA    20 – 80% 
THROMBOPHLEBITIS    
HAEMORRHAGE  
FEMORAL ARTERY BLOW OUT 
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ORGAN SPARING SURGERY FOR CARCINOMA PENIS 
For cancer penis, the issue of quality of life is measured in terms of functional and 
psychological morbidity (125,126,127). Organ sparing dermatological surgical techniques are 
gaining acceptance. Use of these surgical techniques for local control, with an emphasis on 
Mohs Micrographic Surgery (MMS) is discussed. 
MMS was first described in 1930’s by a general surgeon at the University of 
Wisconsin, Fredrick E. Mohs. As a well established form of margin controlled surgery, the 
technique has been producing results unmatched by other modalities of treatment for cutaneous 
SCC. Rowe and associates demonstrated that MMS produces better results for cutaneous SCC 
than all other modalities. Mohs demonstrated MMS to give 94% cure rate in 31 patients of 
Jackson’s I –III. For treatment of penile SCC, MMS produces impressive long term cure rate 
and compares favorably with the more disfiguring technique of partial penectomy (129). 
 
   ORGAN SPARING SURGICAL TECHNIQUES 
1. Laser ablation 
2. Circumcision 
3. Wedge resection 
4. Frozen section guided ellipse excision 
Frozen section controlled techniques are of two types: 
1. standard 
2. Mohs 
Standard excision and Mohs are different in the way in which surgical specimens are 
pathologically processed. This is very important regarding the quality of margin control.  
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Mohs is done as an outpatient procedure using local anesthesia. The overall procedure 
is composed of a series of excisions and pathologic tissue processing described in stages. In 
stage one; the clinically evident tumor is surgically debulked. A two dimensional diagram, “the 
Mohs map” drawn of the specimen relates its orientation to the surgical defect. The concept of 
orienting the tissue specimens horizontally which allows for review of 100% of the surgical 
margins, is unique and is what sets MMS apart from all other techniques of skin cancer 
removal. In addition, the Mohs surgeon does the excision and interprets the pathological 
specimens, thereby further enhancing maintenance of appropriate orientation of tissues.  
TREATMENT OF PRIMARY PENILE CANCER <3.5 CM IN DIAMETER 
 
JACKSONS STAGE 
UICC / TNM 
WELL 
DIFFERENTIATED 
MODERATELY 
DIFFRENTIATED 
POORLY 
DIFFERENTIATED 
I (Tis,T1-2,No,Mo) MMS MMS MMS 
II (T3-4,No,Mo) MMS MMS PP/MMS 
III(T1-4,N1-3,Mo) PP/MMS PP/MMS TP/MMS 
  
(MMS-Mohs micrographic surgery; PP-Partial penectomy; TP-Total penectomy) 
 
  ROLE OF RADIOTHERAPY IN CARCINOMA PENIS 
The principle advantage of radiotherapy is its organ sparing cure with maintenance of 
function. The functional and psychological consequences of undergoing penectomy, whether 
total/ partial can be devastating, particularly in younger patients, and the psychological need 
for normal urinary and sexual function should not be underestimated in the elderly. 
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 The role of radiotherapy involves 
1. Treatment of primary 
2. Treatment of regional lymphatics 
Before radiotherapy, circumcision should be performed both to assess the extent of tumor 
and to minimize the morbidity associated with radiotherapy. Infection, which can happen 
secondary to tumor, should be treated as it increases radio resistance. (133) Fibrosis of the 
foreskin occurs as a late complication, causing an inability to retract the foreskin and impede 
sexual function. In addition, follow up care is better facilitated by the absence of the foreskin, 
which allows for a more thorough tactile and visual examination. 
  
 RADIOTHERAPEUTIC METHODS: 
 1. Superficial X rays    5. Interstitial and contact brachytherapy 
 2. Teleradium sources    6. External beam radiation 
 3. Megavoltage gamma and x rays  7. Electron beams 
 4. Interstitial implants with Iridium 192 
 
   EXTERNAL BEAM RADIOTHERAPY (EBRT) 
Most radiotherapy departments have used Cobalt-60 or 4MV photons with appropriate 
bolus. Most series have treated patients to a total dose of 50-60 Gy in fractions of 2-3.5 Gy 
through parallel opposed fields. Several devices have been designed to achieve a homogenous 
dose like molded wax bolus, plastic box with central opening, water filled containers, Perspex 
tube etc. Bowen’s disease and Erythroplasia of Queyrat which are typically treated with local 
excision or topical 5 FU may respond well to irradiation. 
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External beam radiotherapy can be combined with concurrent chemotherapy. Most 
commonly used chemotherapeutic agents are Bleomycin either alone or with Methotrexate (135)   
  
 COMPLICATIONS OF EBRT: 
1. Dry or moist desquamation  5. Erythema 
2. Atrophy of penile skin   6. Swelling of penis 
3. Urethral strictures    7. Impotence 
4. Radio necrosis of penis   8. Lymph edema of legs 
 
BRACHYTHERAPY 
 Two types of brachytherapy used are: 
1. Contact brachytherapy 
2. Interstitial brachytherapy 
In contact brachytherapy, the radioactive source is placed in contact with the tissues to 
be irradiated. In interstitial type, the radioactive sources are placed inside the tumor bed. Of the 
two, interstitial is used more often. 
Sources used for brachytherapy are 
 * Cobalt 60    * Radium 226 
 * Tantalum 182   * Gold 190  
 * Iridium 192 - Iridium 192 is the most commonly used source. 
  * A dose of 60-65 Gy is delivered. Urethral dose is limited to 50 Gy. Gonads: 8-16 Gy 
* The aim is to treat the tumor with margin of 2 cm proximal to the tumor and 1 cm 
distal to the tip of the penis. 
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METHOD:  1. INTERSTITIAL BRACHYTHERAPY 
Under general/ spinal anesthesia, a Foley’s catheter is inserted and left in place for the 
duration of treatment. A Plexiglas template is placed on each side of the penis and holes are 
drilled in a pattern to match the desired arrangement of the implant. Angiocatheters or 
hypodermic needles which are used as vectors for insertion of the radioactive sources are 
inserted in one or more parallel planes through the tumor bed, oriented perpendicular to the 
axis of the penis. The vectors may be spaced with an intersource distance of 10-22 mm. one 
end of the vector is sealed with lead and radioactive source is inserted and the other end sealed. 
A small sponge placed at the penile base elevates the penis and distance the testicles from 
radioactive sourced.  
    2. CONTACT BRACHYTHERAPY 
 This involves the use of surface mold containing radioactive sources that can be worn 
over the penis. A cylindrical plastic mold is fitted to the penis and an outer mold is constructed 
to slide over the inner mold. The applicator mold (outer mold) can be removed if the patient 
wishes to urinate and kept in lead container at the bedside. The application mold is left in place 
for 10-12 hrs per day over 7-8 days period. 
CONTRAINDICATIONS TO BRACHYTHERAPY: 
1. Tumor size > 4 cm  
2. Major invasion of corpora cavernosum (> 1cm invasion) 
In general, brachytherapy with surgical salvage in the event of failure has been shown to 
produce results equivalent to those of primary surgery, the principle advantage being sparing 
the organ and the psychological sequelae following that and the much shorter time of treatment 
than that of EBRT. 
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 COMPLICATIONS OF BRACHYTHERAPY 
1. Erythema 
2. Edema of subcutaneous tissue 
3. Urethral mucositis 
4. Telangiectasia, dyschromia & superficial sclerosis 
5. Urethral stenosis 
6. Radio necrosis (occurs within 18 months after completion of treatment) 
6% of Patients treated with brachytherapy required amputation for complications.  
  
 RADIOTHERAPY FOR REGIONAL LYMPHATICS 
Comparison of survival rates in patients who underwent lymphadenectomy or 
radiotherapy for either prophylactic or therapeutic treatment of groin (137) 
MODE OF TREATMENT 
(PROPHYLACTIC) 
3 YEARS 5 YEARS 
SURGERY 64% 50% 
RADIOTHERAPY 44% 44% 
 
  
MODE OF TREATMENT 
(THERAPEUTIC) 
3 YEARS 5 YEARS 
SURGERY 52% 34% 
RADIOTHERAPY 27% 30% 
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Elective irradiation of clinically uninvolved groins, known to be of benefit for 
squamous cell cancers at other sites (eg. Head and neck, cervix) is of uncertain benefit for 
penile cancer. Patients who present with extensive or poorly differentiated tumors may benefit 
from elective groin irradiation. Both the inguinal and pelvic nodes should be treated. 
Megavoltage X rays using parallel opposed fields should be used. Weighted photons may also 
be used. 
 DOSE: 
 Prophylactic - 50 Gy 
 Therapeutic - 65-70 Gy 
 
  ROLE OF CHEMOTHERAPY IN CARCINOMA PENIS 
 Recently it has become possible to verify the reproducible efficacy of some 
combination regimes and to suggest a more rational use of chemotherapy in multimodality 
treatment. Combination chemotherapy is expected to improve cure rates in patients with nodal 
metastasis. 
 
Indications for chemotherapy in carcinoma penis: 
1. systemic therapy in rare cases of distant metastasis 
2. Neo adjuvant chemotherapy for fixed inguinal nodes. 
3. Adjuvant therapy after nodal resection. 
4. As a combined modality of treatment in organ sparing therapy in selected cases. 
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Drugs used:   
Single agent: Bleomycin 
   Methotrexate 
   Cisplatin 
 Combination chemotherapy: 
1. Alsarraf regimen:Cisplatin + 5FU (PF) 
2. Methotrexate + Bleomycin + Cisplatin (MBC) 
3. Vincristine + Bleomycin + Methotrexate (VBM) 
Combination chemotherapy achieves better results than single agent chemotherapy. Of the 
three regimes VBM is the easiest to administer. The two cisplatin containing regimens seem to 
be more effective and the MBC regimen is the most toxic. Alsarraf and VBM regimens provide 
better results. 
DOSE: 
PF (ALSARRAF) REGIMEN: 
 Cisplatin 100 mg/m2 IV day 1 
 5 FU  1000mg/m2 IV infusions daily 1-4 days 
 
 VBM REGIMEN 
 Vincristine 1 mg IV day 1 
 Bleomycin 15 mg IM 6 &12 hrs after Vincristine 
 Methotrexate 30 mg oral on day 3 
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   MATERIALS AND METHODS 
 
 
 Analysis of 45 patients of carcinoma penis from the period of June 2005 to September 
2007 at Government Royapettah Hospital & Kilpauk medical college, Chennai. 
 
 At presentation history is taken; relevant points are noted and staged. Biopsy is taken 
for pathological diagnosis and grade. 
 
 Clinical assessment of the regional lymph nodes is done and recorded. FNAC of the 
enlarged lymph nodes is done. 
 
 Investigations were done and patients were taken up for surgery. Surgery for the 
primary and nodes were recorded and the post surgical histopathology is obtained and patients 
followed up.   
 
 Patients presenting with inguinal nodes alone after primary surgery done at different 
places were also included retrospectively. 
 
 The data obtained were recorded in a specific proforma designed for the purpose and 
analyzed in a systematic way and conclusions drawn. 
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   OBSERVATIONS AND DISCUSSION 
 
Analysis of 45 cases from June 2005 to September 2007. 
 
Definition of cases included only those confirmed to have squamous cell carcinoma of penis 
histopathologically 
There was no uniformity in the therapy followed. Different plan of treatment depended on the 
T stage, grade of the tumor, presence of inguinal nodes and patient’s general condition.  
AGE WISE INCIDENCE:     
OUR STUDY, 
GOVT. ROYAPETTAH HOSPITAL,  
KILPAUK MEDICAL COLLEGE, 
CHENNAI, JUNE 2005-SEP 2007 
FLETCHNER C DERRICK, 
MEDICAL UNIVERSITY OF SOUTH 
CARDINA, 1946-1966, 
JOURNAL OF UROLOGY; VOL 110 
AGE NO. OF CASES AGE NO. OF CASES 
20-30 1 20-29 1 
30-40 7 30-39 9 
40-50 20 40-49 24 
50-60 10 50-59 19 
60-70 3 60-69 25 
>70 4 70-79 7 
TOTAL 45 80-89 2 
  TOTAL 87 
MODE 45 YEARS MODE 65 YEARS 
 
The age wise incidence in western studies show peak incidence in 60-70 years. In our study the 
peak incidence is 40-50 years. 
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COMPARISON OF AGE WISE INCIDENCE WITH WESTERN STUDIES 
 
STUDY     AGE IN YEARS  
 
 Kamal A. Hanash, Minnesota (1945-1965)   68 years 
Begg & Spratt (1961)      69 years 
Hardnes (1970)      67 years 
Our study (2005-2007)     45 years 
 
This lower age incidence is due to the fact that in countries where the overall incidence of 
carcinoma penis is higher, the peak incidence is at lower age. 
 
A G E  W I S E  I N C I D E N C E
2 0 - 3 0 3 0 - 4 0
4 0 - 5 0
5 0 - 6 0
6 0 - 7 0 > 7 0
2 0 - 3 0 3 0 - 4 0 4 0 - 5 0 5 0 - 6 0 6 0 - 7 0 > 7 0
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SYMPTOMS AT PRESENTATION 
The commonest symptom of presentation in our report is Growth: 23 cases. 
The other presenting symptoms were: 
 
SYMPTOMS NUMBER OF CASES PERCENTAGE 
Growth 23 51.1 
Ulcer 20 44.4 
Discharge 10 22.2 
Groin mass 4 8.9 
Urinary symptoms 3 6.7 
Edema & inflammation 2 4.4 
  
 
    Hanash & Associates 1965 
 
SYMPTOMS NUMBER OF CASES PERCENTAGE 
Ulcer 66 39 
Growth 67 39.6 
Node 6 3.6 
Discharge 21 12.4 
Edema & cellulitis 9 5.3 
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DURATION OF SYMPTOMS: 
Average duration  : 9.5 months 
Comparing age group and duration of symptoms 
Age group Average duration in months 
20-30 6.7 
30-40 10.2 
40-50 9.6 
50-60 8.9 
60-70 10.4 
>70 11.3 
 
 The average duration of symptoms in our patients is 9.5 months. In contrast the western 
studies show an average duration of symptoms to be less than 3 months. 
 Our patients ignore the symptoms for a long time. Patient with an ulcer and discharge 
come early than a patient with proliferative lesion. 
Younger patients seek medical attention much earlier than older patients. No strict 
comparison was possible as the duration of symptoms depend on many factors like literacy, 
socioeconomic status, accessibility. 
 
SITE OF ORIGIN: 
The most common site of origin in our study is the Glans. 
This result confirms the literature reports that glans is the most common site followed by 
prepuce, coronal sulcus and shaft, in that order. 
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SITE OF ORIGIN NUMBER PERCENTAGE 
GLANS 26 57.8% 
PREPUCE 12 26.7% 
CORONAL SULCUS 6 13.3% 
SHAFT 1 2.2% 
 
 Comparing this with a review of large series of penile cancer by Sufrin G, Huben R 
(Ref: benign and malignant lesions of the penis. In Gillenwater Jyed Adult and pediatric 
urology 2nd edition Chicago year book 1991:1643) 
 
GLANS 48% 
PREPUCE 21% 
CORONAL SULCUS 6% 
SHAFT 2% 
BOTH GLANS & PREPUCE 9% 
 
 STAGE AT PRESENTATION: 
 In our study most of the cases presented at stage III 
OUR STUDY BARNES ET AL CAPETOWN, S.A,1968-85 
STAGE 
(JACKSON'S) 
NO.OF 
CASES % 
STAGE 
(JACKSON'S) 
NO. OF 
CASES % 
I 5 11.10% I 27 44% 
II 10 22.20% II 17 27% 
III 27 60% III 12 19% 
IV 3 6.60% IV 6 10% 
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ETIOLOGICAL FACTORS: 
 Analyzing the etiological factors of 45 cases studied, none of the cases occurred in 
circumcised penis. One patient reported history of cancer cervix in the sexual partner. 
Association of HPV and cancer penis could not be studied since HPV testing was not done in 
any of the cases.  
 History of recurrent preputial infection and history of STD was elicited in 3 patients. 
Again a strong relationship could not be documented as the number is small. Two of the cases 
reported having premalignant lesion- leukoplakia, on which the cancer occurred. 
 
TYPE OF LESION: 
The lesions were either ulcerative or proliferative. Ulcerative lesion was seen in 24 cases and 
proliferative in 21 cases. Ulceroproliferative cases were taken as proliferative lesions. 
OUR STUDY 
ULCERATIVE 24 53.3% 
PROLIFERATIVE 21 46.7% 
TOTAL 45 100% 
 
NODAL STATUS: 
 Of the 45 cases studied, 30 cases (67%) presented with clinically palpable nodes at 
presentation. But only 11 were positive (36.7%) by fine needle aspiration biopsy (FNAC). Of 
these 11, 3 were inoperable inguinal nodes and hence radiotherapy was given to them, and the 
other 8 cases underwent ilio inguinal block dissection at the first sitting. Remaining 19 
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clinically node palpable cases in which FNAC was negative were kept on follow up with 
antibiotics, of which 6 of them developed pathological positivity later. Altogether 17 cases 
(56.7%) developed pathological positive nodes among node palpable 30 cases. Remaining 13 
cases (43.3%) remained inflammatory and regressed. This confirms with the reports in 
literature that approximately 50% of the clinically palpable nodes at presentation are 
inflammatory. 
67% Cases presented with palpable nodes 
56.7% Pathologically positive 
43.3% Regressed with antibiotics 
 
 Of the total 17 pathologically positive cases, initial FNAC was able to detect only 11 
of it indicating its sensitivity to be about 65%. 
 Of the total 45 cases, 15 cases did not have clinically palpable nodes at presentation. 
But however in 3 cases, nodes appeared during follow up and were pathologically documented. 
When the patients presented with nodal metastasis, nodes were already fixed and inoperable 
and only salvage chemotherapy and radiotherapy could be instituted. 
 
No. of cases % Nodal status 
15 33.3% Nodes not palpable 
3 20% False negative 
12 80% Negative nodes 
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Overall of the 45 cases studied, the nodal status is given below: 
 OUR STUDY: 
NODES CLINICALLY PATHOLOGICALLY 
POSITIVE 30 17 
NEGATIVE 15 12 
 
 STUDY BY J.HARDENER 
NODES CLINICALLY PATHOLOGICALLY 
POSITIVE 48 20 
NEGATIVE 52 38 
 
Clinically positive nodes turning pathologically negative: 43.3% 
Clinically negative nodes turning pathologically positive: 20% 
 Our study confirms the literature studies’ that 50% of clinically palpable nodes are 
inflammatory and 20% of clinically negative nodes harbor occult metastasis. The number of 
inflammatory enlargement of nodes is slightly higher in our study compared to western study 
because of lack of personal hygiene and the secondary infection rate of the primary lesion is 
greater. 
Comparison study 
Kamal A et al 1965 : 58% nodes were pathologically -ve 
Dr.N. Anandakrishan : 50% Positivity 
Begg and Spratt 1961 : 80% of clinically –ve nodes were pathologically -ve 
20% of –ve nodes contained occult metastasis. 
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FACTORS ASSOCIATED WITH NODAL INVOLVEMENT 
 Only the pathologically involved nodes are taken up for analyzing the associated 
factors. Of the 17 patients who had pathologically positive nodes in our study, the underlying 
factors are individually analyzed. 
 
Age:  
Age No. of cases No. of node positive cases Percentage 
20-30 1 0  
30-40 7 2 28.5 
40-50 20 9 45 
50-60 10 3 30 
60-70 3 2 66.7 
>70 4 1 25 
Total 45 17  
 
Site of origin: 
Site Node positive Node negative Total 
Glans 11 19 26 
Prepuce 3 13 12 
Coronal sulcus 2 4 6 
Shaft 1 - 1 
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Type of lesion: 
Morphology Node positive Node negative Total 
Ulcer 11 13 24 
Growth 6 15 21 
 
Grade of the tumor: 
Grade Node +ve Node -ve Total % 
Well differentiated 3 20 25 12 
Moderately differentiated 11 8 17 64.7 
Poorly differentiated 3 - 3 100 
 
Poorly differentiated and moderately differentiated tumors had a very strong association with 
nodal involvement. 
 
COMPARISON STUDY: 
1.  The study by Fraley et al 1989, Ravi 1993 Hozenblum associates showed that higher 
grade was associated with increased nodal spread. 
2.  The study reports by Dean 1935, Maveral et al 1962, and Ornellas et al 1994, all 
showed that ulcerative growth had earlier nodal metastasis than proliferative type of 
lesion. 
3.  John H Beggs & John S.Spratt 1961 showed that shaft involvement was associated with 
increased incidence on nodes. If the proximal shaft was involved the risk was more. 
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TREATMENT 
 In almost all the patients, surgery was the prime modality of treating the primary. 
Three patients presented with inoperable disease and hence were given radiotherapy. 
 The type of surgery was either partial or total amputation with perineal urethrostomy 
and emasculation. Circumcision alone was used as a treatment in any of the 45 cases. 
Type of surgery Number of cases % 
Partial amputation 28 66.7% 
Total amputation + urethrostomy 14 33.3% 
 
 In almost all the patients who presented with advanced lesions, none of them were 
suitable candidates for radiotherapy as the primary modality. Radiotherapy was employed only 
in inoperable cases as far as the treatment of primary is concerned. There had been no 
mortality so far in the follow up period even in the patients employed radiotherapy. However 
radiotherapy was widely used in managing the groin.  
 The regional nodes were either given radiotherapy or ilioinguinal block dissection. 
Initial 3 patients who presented with inoperable disease and 3 patients who developed 
inoperable inguinal metastasis after primary surgery were given radiotherapy. 
Type of treatment Number Percentage 
Radiotherapy 6 35.2% 
Ilioinguinal block dissection 11 64.7% 
Total 17 100% 
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COMPLICATIONS 
The primary lesion was secondarily infected in many of the cases. Meatal stenosis and urethral 
stricture was observed in 3 cases. All underwent instrumental dilatation.  
At the primary site minor wound infection occurred postoperatively.  
4 cases developed flap necrosis, 1 case had a sinus tract at the operated site which was excised. 
One case developed ulceration at the perineal urethrostomy site.  
 
FOLLOW UP 
 The cases were followed for a period ranging from 6 months to 2 years. For the 
primary lesion 2 cm clearance was adequate in all cases of partial amputation and no 
recurrence was noted 
 All the recurrences were only at the regional nodes. All the 3 cases which developed 
fixed nodes on follow up in the clinically node impalpable group of 15 patients came only after 
a long gap of almost an year and are at present being treated by radiotherapy.  On analyzing the 
cases that recurred, several factors like T stage, grade of the tumor, size of the lesion and 
morphological type, whether ulcerative or proliferate played a role. Hence these factors should 
be taken into account while deciding on the treatment modality.  
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RESULTS 
1. The maximum incidence was found to be in the age group 40-50. 
2. Carcinoma penis was found to occur in a younger age group compared to western studies. 
3. Commonest symptom of presentation was growth (51.1%) 
4. The most common site of origin was Glans penis 
5. Ulcerative lesion was more common than proliferative type (53.3%) 
6. 67% of cases presented with palpable nodes at presentation. 
7. 56.7% of the palpable nodes were pathologically positive. 
8. 33.3% of cases did not have palpable nodes at presentation. 
9. 20% of clinically negative nodes harbored metastasis. 
10. Sensitivity of FNAC was about 64.7%. 
11. The average time interval between onset of symptoms and seeking medical advice is 9.5 
months which is more than western population. 
12. Ulcerative lesions had a slightly higher incidence of nodal involvement.  
13. Lesions originating from the prepuce had less incidence of nodal involvement when 
compared to lesions originating from corona and shaft 
14. Moderately and poorly differentiated tumors had a very strong association with nodal 
involvement. 
15. Surgery was the primary modality used in the treatment of both primary and secondary.  
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CONCLUSION 
 
 The incidence of palpable nodes at presentation in our study was higher when 
compared to western studies. However the incidence of pathologically involved nodes is 
similar. The remaining nodes were inflammatory. This was due to higher rate of secondary 
infection in our patients due to poor personal hygiene.  
 Ulcerative lesions, higher stage and grade were more associated with nodal 
involvement. These factors should be considered while planning the treatment of inguinal 
nodes.  
 Only 56.7% of the clinically palpable nodes were actually positive pathologically 
and 20% of clinically negative nodes eventually developed metastasis.  
 Carcinoma penis occurred at a lower age compared to western population. 
 Most of the patients presented in stage III and average delay in seeking advice is 
around 9 months. Ulcerative type of lesion was more common and commonest site of origin 
was Glans. 
 Surgery was the main modality of treatment adopted for the primary and 
pathologically positive secondaries. However nodal metastasis were found in patients managed 
conservatively for the clinically negative groin in high grade primary treated by surgery.  
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1 GOVINDAN 32 886562 H U 1yr  - GL U  -  - MD T1 N0 M0 II PA  -  -  -  -  - 
2 GANAPATHY 41 884456 H G 1yr  - P G  +  - WD T1 N1 M0 III TA  -  -  -  -  - 
3 KARTHIKEYAN 54 884333 H U,N 9m  - GL U  +  + MD T2 N1 M0 II TA IIBD  -  - FN  - 
4 VEDACHALAM 33 887645 H G 11m  - GL G  -  - WD T1 N0 M0 I PA  -  -  -  -  - 
5 ARULANANTHAM 44 886532 H U 9m  - P U  -  - MD T2 N1 M0 III TA  -  +  +  - RT 
6 DESAPPAN 55 889675 H D 8m  - C U  +  + PD T2 N3 M0 IV RT RT  -  -  -  - 
7 KARUNANIDHI 38 889343 H G,Ur 9m  - GL G  -  - WD T1 N0 M0 II PA  -  -  - MS  - 
8 RAMAMOORTHY 57 888965 H U 10m  - GL U  +  - WD T1 N1 M0 III PA  -  -  -  -  - 
9 PONNUSAMY 43 883434 H G 8m  - P G  +  + MD T1 N2 M0 III TA IIBD  -  -  -  - 
10 MUNIYAN 58 886555 H U 10 m  - GL U  +  - WD T1 N1 M0 III PA  -  -  -  -  - 
11 MAHALINGAM 37 879887 H G 9 m  - GL G  -  - WD T1 N0 M0 I PA  -  -  -  -  - 
12 KALIYAN 47 891234 H U,N 10 m  -  GL U  +  + MD T2 N2 M0 III TA IIBD  -  - 
 
FN  - 
13 RAMAIAH 46 878988 H G,D 6 m  - GL G  +  - WD T2 N1 M0 III PA  -  -  -  -  - 
15 GOVINDAN 49 884450 H U 1yr  - GL U  -  - MD T1 N0 M0 II PA  -  -  -  -  - 
16 GANAPATHY 50 884233 H G 1yr  - P G  +  - WD T1 N1 M0 III TA  -  -  -  -  - 
17 KARTHIKEYAN 51 884015 H U,N 9m  - GL U  +  + MD T2 N1 M0 II TA IIBD  -  - FN  - 
18 VEDACHALAM 51 883798 H G 11m  - GL G  -  - WD T1 N0 M0 I PA  -  -  -  -  - 
19 ARULANANTHAM 52 883581 H U 9m  - P U  -  - MD T2 N1 M0 III TA  -  +  +  - RT 
20 DESAPPAN 53 883364 H D 8m  - C U  +  + PD T2 N3 M0 IV RT RT  -  -  -  - 
21 KARUNANIDHI 53 883147 H G,Ur 9m  - GL G  -  - WD T1 N0 M0 II PA  -  -  - MS  - 
22 RAMAMOORTHY 54 882930 H U 10m  - GL U  +  - WD T1 N1 M0 III PA  -  -  -  -  - 
23 PONNUSAMY 55 882713 H G 8m  - P G  +  + MD T1 N2 M0 III TA IIBD  -  -  -  - 
24 MUNIYAN 55 882496 H U 10 m  - GL U  +  - WD T1 N1 M0 III PA  -  -  -  -  - 
25 MAHALINGAM 56 882279 H G 9 m  - GL G  -  - WD T1 N0 M0 I PA  -  -  -  -  - 
26 RAMU 64 891222 H U 11m  - C U  +  - MD T1 N0 M0 II PA IIBD  -  -   - 
MASTER CHART 
  
 
(H- Hindu, C- Christian, U- Ulcer, G- Growth, Ur- Urinary symptoms, D- Discharge, E & C- Edema & Cellulitis, N- Node, GL- Glans,                  
P- Prepuce,  C- Corona, S- Shaft, WD- Well Differentiated, MD- Moderately Differentiated,  PD- Poorly Differentiated, PA- Partial 
Amputation, TA- Total Amputation, IIBD- Ilio Inguinal Block Dissection, RT- Radio Therapy, MS- Meatal Stenosis, FN- Flap Necrosis, ST- 
Sinus Tract ) 
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27 MARIMUTHU 41 885674 H U 10 m  - P U  +  - WD T1 N1 M0 III PA  -  -  -  -  - 
28 KALIMUTHU 42 886734 H G,Ur 6 m  - C G  -  - MD T2 N1 M0 III TA  -  -  + MS  - 
29 DASS 55 891256 C G 7 m  - GL G  +  - WD T1 N1 M0 III PA  -  -  -  -  - 
30 CHANDRAN 46 891476 H G,D 7 m  - GL G  +  + WD T1 N1 M0 III PA IIBD  -  -  -  - 
31 MUNIYANDI 78 884367 H G,D,E,C 14 m  - C G  -  - WD T2 N0 M0 I TA  -  -  -  -  - 
32 DEVAN 47 878956 H U 9 m  - GL U  +  + MD T2 N2 M0 III TA IIBD  -  - FN  - 
33 PRASANNA 25 892367 H D,U 7 m  - P U  -  - WD T1 N0 M0 II PA  -  -  -  -  - 
34 SUBRAMANI 44 884653 H G 10 m  - GL G  +  + MD T1 N1 M0 III PA IIBD  -  -  -  - 
35 ESWARAN 41 886793 H U 9 m  - P U  -  - WD T1 N0 M0 I PA  -  -  -  -  - 
36 ARIVALAN 64 887456 C D,U 11 m  - P U  +  + PD T2 N3 M0 IV RT RT  -  -  -  - 
37 CHOCKALINGAM 56 891143 H G 8 m  - GL G  +  - WD T1 N1 M0 III PA  -  -  -  -  - 
38 GOPAL 79 878567 H U,N 10 m  - GL U  +  - MD T2 N1 M0 III TA  -  -  -  -  - 
39 DORAISAMY 59 887654 H G 8 m  - GL G  +  - WD T1 N1 M0 III PA  -  -  -  -  - 
40 CHINNAPA 42 891145 H U 10 m  - P U  -  - MD T1 N0 M0 II PA  -  +  -  - RT 
41 SRINIVASAN 65 891243 H E,C,G 9 m  - C G  +  - WD T1 N1 M0 III PA  -  -  -  -  - 
42 PARTHIBAN 51 885673 H G 8 m  - GL G  -  - WD T1 N0 M0 I PA  -  -  -  -  - 
43 VENKATESH 47 884593 H D 15 m  - GL U  +  + MD T2 N2 M0 III TA RT  -  +  -  - 
44 VEMBULI 52 894567 H U 7 m  - GL U  +  + MD T2 N1 M0 III TA IIBD  -  -  -  - 
45 VENKAIAH 48 883478 H D,U 7 m  - P U  -  - WD T1 N0 M0 II PA  -  -  -  -  - 
